Literature DB >> 1671549

Somatostatin inhibits the nicotinic receptor-activated inward current in guinea pig chromaffin cells.

M Inoue1, H Kuriyama.   

Abstract

At a holding potential of -60 mV, bath application of somatostatin produced no current response itself, but inhibited the nicotinic inward current, a concentration of about 0.01 microM being required for a half-maximal effect. This inhibition was affected neither by pretreatment with somatostatin nor by injection of guanosine-5'-0-(3-thiotriphosphate) through a patch pipette. When somatostatin (0.03-0.1 microM) produced its maximum inhibition, the proportion of plateau to peak nicotinic current was greatly reduced (to 5.3 +/- 5.7% from the control value of 34.9 +/- 4.9%, n = 5) with a facilitation of the time course of desensitization. After washout of somatostatin, the nicotinic current was restored to control level in a time-dependent, rather than an activation-dependent manner. The results suggest that somatostatin inhibits the function of the nicotinic receptor by facilitation of its desensitization or by an open-channel block.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1671549     DOI: 10.1016/0006-291x(91)91481-q

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  1 in total

1.  Inhibition of nicotinic receptor-mediated responses in bovine chromaffin cells by diltiazem.

Authors:  L Gandía; M Villarroya; F Sala; J A Reig; S Viniegra; J L Quintanar; A G García; L M Gutiérrez
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.